Venture Investors leads Series A round for Madison Vaccines
Madison Vaccines said Monday that it has raised $8 million in Series A funding. Venture Investors led the round with participation from Wisconsin Alumni Research Foundation, Venture Management and the State of Wisconsin Investment Board. Based in Madison, Wisc., Madison Vaccines is a biopharmaceutical company focused on treating prostate cancer.
13 January 2014•4 mins read
